These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9876536)

  • 1. Comparative evaluation of surfactant and hydrophobizing agent concentration in relation to the optimal particle size of metered-dose inhalers.
    Fedina LT; Zelkó R; Fedina LI; Szabados Z; Szántó M
    Drug Dev Ind Pharm; 1998 Sep; 24(9):853-6. PubMed ID: 9876536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of auxiliary materials on the proportion of effective particle size of metered-dose suspension type aerosols].
    Fedina L; Zelkó R; Fedina L; Szabados Z; Szántó M; Vakulya G
    Acta Pharm Hung; 1998 Jul; 68(4):220-3. PubMed ID: 9737022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of surfactant and suspending agent concentration on the effective particle size of metered-dose inhalers.
    Fedina LT; Zelkó R; Fedina LI; Szabados ZS; Szántó M; Vakulya G
    J Pharm Pharmacol; 1997 Dec; 49(12):1175-7. PubMed ID: 9466338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the formulation parameters on the characteristics of pellets.
    Fekete R; Zelkó R; Marton S; Rácz I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anionic surfactant with hydrophobic and hydrophilic chains for nanoparticle dispersion and shape memory polymer nanocomposites.
    Iijima M; Kobayakawa M; Yamazaki M; Ohta Y; Kamiya H
    J Am Chem Soc; 2009 Nov; 131(45):16342-3. PubMed ID: 19852463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers.
    Feddah MR; Davies NM
    J Pharm Pharmacol; 2003 Aug; 55(8):1055-61. PubMed ID: 12956894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partitioning of hydrophobic pesticides within a soil-water-anionic surfactant system.
    Wang P; Keller AA
    Water Res; 2009 Feb; 43(3):706-14. PubMed ID: 19026434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functionality of inhalation aerosols is inadequate or lost at low temperature].
    Lundgren HW; Holmér I; Lidén G
    Lakartidningen; 2001 Mar; 98(13):1508-11. PubMed ID: 11330145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica nanoparticles at interfaces modulated by amphiphilic polymer and surfactant.
    Alves de Rezende C; Lee LT; Galembeck F
    Langmuir; 2008 Jul; 24(14):7346-53. PubMed ID: 18547078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metered dose inhalers and spacer devices.
    Terzano C
    Eur Rev Med Pharmacol Sci; 1999; 3(4):159-69. PubMed ID: 11073122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic azobenzenesulfonic acid anionic surfactant for water-soluble, ordered, and luminescent polypyrrole nanospheres.
    Antony MJ; Jayakannan M
    J Phys Chem B; 2007 Nov; 111(44):12772-80. PubMed ID: 17944509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Turbuhaler].
    Braunstein G
    Rev Mal Respir; 1992; 9 Suppl 1():R83-6. PubMed ID: 1589636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of sorbitan trioleate in metered-dose inhalers by supercritical-fluid chromatography.
    Di Maso M; Purdy WC; McClintock SA; Cotton ML
    J Pharm Biomed Anal; 1990; 8(3):303-5. PubMed ID: 2094430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Suspension aerosols. III. Effect of various surface-active agents on aggregation of particles].
    Pietura A; Zakrzewski Z; Katarzyńska U
    Acta Pol Pharm; 1978; 35(4):477-82. PubMed ID: 707159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.